Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Abingdon Health PLC ( (GB:ABDX) ) just unveiled an update.
Abingdon Health PLC has successfully raised approximately £3.4 million through a Retail Offer and Placing, with the issuance of new shares expected to commence trading on AIM on 31 October 2025. This financial move is anticipated to enhance the company’s operational capabilities and strengthen its market position in the med-tech industry, providing potential growth opportunities for stakeholders.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider that specializes in rapid diagnostic tests and offers a range of services including lateral flow product development, regulatory support, technology transfer, and manufacturing. The company serves an international customer base across sectors such as infectious disease, clinical testing, animal health, and environmental testing. Founded in 2008, it is headquartered in York, England, with additional facilities in Doncaster, England, and Madison, Wisconsin, USA.
Average Trading Volume: 152,267
Technical Sentiment Signal: Sell
Current Market Cap: £12.1M
Find detailed analytics on ABDX stock on TipRanks’ Stock Analysis page.